Academic application of Good Cell Culture Practice for induced pluripotent stem cells
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Human induced pluripotent stem cells (hiPSC) are a promising tool for replacing animal-based experiments. To warrant data reproducibility, quality-controlled research material is recommended. While the need for global harmonization of quality standards for stem cell banking centers, commercial providers, pre-clinical and clinical use of cells is well documented, there are no recommendations available for quality control of hiPSC in an academic research environment to date. To fill this gap, we here give an example of a quality-controlled, two-tiered banking process producing a fully characterized master cell bank (MCB) and partially characterized respective working cell banks (WCB). Characterization includes the study of morphology, mycoplasma contamination, cell line identity, karyotype stability, cell antigen expression and viability, gene expression, pluripotency, and post-thaw recovery. Costs of these procedures are calculated. We present the results of the proposed testing panel of two hiPSC MCBs and show that both fulfil the defined specifications regarding the above-mentioned characterization assays during and upon banking. In conclusion, we propose a panel of eight assays, which are practical and useful for an academic research laboratory working with hiPSCs. Meeting these proposed specifications ensures the quality of pluripotent stem cells throughout diverse experiments at moderate costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1,500 scientists lift the lid on reproducibility
Baker, M. (2016) · Nature · doi:10.1038/533452a · Cited by 4,209
Origins and functional impact of copy number variation in the human genome
The Wellcome Trust Case Control Consortium, Conrad, D. F., Pinto, D., Redon, R., Feuk, L., Gokcumen, O., Zhang, Y., Aerts, J., Andrews, T. D., Barnes, C., et al. (2010) · Nature · doi:10.1038/nature08516 · Cited by 1,970
Guidelines for investigating causality of sequence variants in human disease
MacArthur, D. G., Manolio, T. A., Dimmock, D. P., Rehm, H. L., Shendure, J., Abecasis, G. R., Adams, D. R., Altman, R. B., Antonarakis, S. E., Ashley, E. A., et al. (2014) · Nature · doi:10.1038/nature13127 · Cited by 1,224
Kattman, S. J., Witty, A. D., Gagliardi, M., Dubois, N. C., Niapour, M., Hotta, A., Ellis, J., & Keller, G. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.008 · Cited by 1,159
Bock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z. D., Ziller, M., Croft, G. F., Amoroso, M. W., Oakley, D. H., et al. (2011) · Cell · doi:10.1016/j.cell.2010.12.032 · Cited by 1,009
The Cellosaurus, a Cell-Line Knowledge Resource
Bairoch, A. (2018) · Journal of Biomolecular Techniques JBT · doi:10.7171/jbt.18-2902-002 · Cited by 807 · cited 4×
“1 mL prewarmed (37°C) trypsin was added to the cells and incubated 1Cellosaurus CVCL_0347 Web page Cellosaurus cell line IMR-90 (CVCL_0347). https://web.expasy.org/cellosaurus/CVCL_0347 (accessed 18.01.2021) ALTEX 38(4), 2021 601 (USA) on dry ice where the PluriTest™ assay (#A38154) was performed.”
BackgroundInfluentialCommon genetic variation drives molecular heterogeneity in human iPSCs
Kilpinen, H., Goncalves, A., Leha, A., Afzal, V., Alasoo, K., Ashford, S., Bala, S., Bensaddek, D., Casale, F. P., Culley, O. J., et al. (2017) · Nature · doi:10.1038/nature22403 · Cited by 586 · cited 1×
“Certain types of aneuploidy have been recurrently identified in hiPSC cultures, including partial or complete gain of chromosome 8, 12, 17, or 20, trisomy X, and chromosome 1 amplification (Mayshar et al., 2010; Amps et al., 2011; Taapken et al., 2011; Kilpinen et al., 2017; Assou et al., 2018).”
BackgroundThe Costs of using Unauthenticated, Over-Passaged Cell Lines: How Much more Data do we Need?
Hughes, P., Marshall, D., Reid, Y., Parkes, H., & Gelber, C. (2007) · BioTechniques · doi:10.2144/000112598 · Cited by 434 · cited 1×
“Up to 40% of all analyzed cell lines have been falsely identified (Nelson-Rees et al., 1981; MacLeod et al., 1999; Stacey et al., 2000; Buehring et al., 2004; Hughes et al., 2007; Rojas et al., 2008; Dirks et al., 2010; Yu et al., 2015).”
BackgroundCoecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.-W., Price, A., Schechtman, L., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300313 · Cited by 371 · cited 3×
“One of the most important principles of Good Cell Culture Practice is cell line authentication (Coecke et al., 2005; Yaffe et al., 2016).”
BackgroundMethodDrexler, H. G., & Uphoff, C. C. (2002) · Cytotechnology · doi:10.1023/a:1022913015916 · Cited by 340 · cited 2×
“…et al., 1989), changes in cellular morphology, growth and viability (Rottem and Barile, 1993; Langdon, 2004), occurrence of chromosomal aberrations (Drexler and Uphoff, 2002), altered cellular metabolism (Armstrong et al., 2010), changes in cell membrane antigenicity (Timenetsky et al., 2006),…”
BackgroundCross-contamination of cells in culture
Nelson-Rees, W. A., Daniels, D. W., & Flandermeyer, R. R. (1981) · Science · doi:10.1126/science.6451928 · Cited by 329 · cited 1×
“Up to 40% of all analyzed cell lines have been falsely identified (Nelson-Rees et al., 1981; MacLeod et al., 1999; Stacey et al., 2000; Buehring et al., 2004; Hughes et al., 2007; Rojas et al., 2008; Dirks et al., 2010; Yu et al., 2015).”
BackgroundKaryotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells
Taapken, S. M., Nisler, B. S., Newton, M. A., Sampsell-Barron, T. L., Leonhard, K. A., McIntire, E. M., & Montgomery, K. D. (2011) · Nature Biotechnology · doi:10.1038/nbt.1835 · Cited by 327
No raw data, no science: another possible source of the reproducibility crisis
Miyakawa, T. (2020) · Molecular Brain · doi:10.1186/s13041-020-0552-2 · Cited by 268 · cited 2×
“de) entist’s or even their own experiments, respectively (Baker and Penny, 2016; Miyakawa, 2020).”
BackgroundInfluentialA resource for cell line authentication, annotation and quality control
Yu, M., Selvaraj, S. K., Liang-Chu, M. M. Y., Aghajani, S., Busse, M., Yuan, J., Lee, G., Peale, F., Klijn, C., Bourgon, R., et al. (2015) · Nature · doi:10.1038/nature14397 · Cited by 225
Fixing problems with cell lines
Lorsch, J. R., Collins, F. S., & Lippincott-Schwartz, J. (2014) · Science · doi:10.1126/science.1259110 · Cited by 179 · cited 2×
“…2018) and are widely applied in forensic analysis (Almeida et al., 2016), but spontaneous mutations or epigenetic changes due to long term culture (Lorsch et al., 2014) and the possible cross-contamination with cell lines from other species (e.g., mice) will not be detected (Freedman et al.,…”
BackgroundGuidance Document on Good In Vitro Method Practices (GIVIMP)
OECD (2018) · OECD Series on Testing and Assessment · doi:10.1787/9789264304796-en · Cited by 161 · cited 2×
“While there is guidance available for Good In Vitro Methods Practices in general (OECD, 2018) or stem cell-based Good Cell Culture Practice specifically (Pamies et al., 2017, 2018, 2020), giving detailed insights into the broad subject of quality assurance (QA) and quality control (QC) of in vitro…”
BackgroundMethodGood Cell Culture Practice for stem cells and stem-cell-derived models
Pamies, D. (2016) · ALTEX · doi:10.14573/altex.1607121 · Cited by 160 · cited 33×
“It has been reported that a post-thaw recovery assessment directly at the time of thawing might be misleading regarding the integrity of the cells (Pamies et al., 2017), therefore we chose to analyze the banked cells when they were split the first time after thawing and assessed the confluency of…”
BackgroundMethodResultInfluentialReproducibility: changing the policies and culture of cell line authentication
Freedman, L. P., Gibson, M. C., Ethier, S. P., Soule, H. R., Neve, R. M., & Reid, Y. A. (2015) · Nature Methods · doi:10.1038/nmeth.3403 · Cited by 136 · cited 2×
“10 52-plex SNP assays seem to have the same rate of discrimination as 16-plex STR assays, but a centralized, online reference database for SNP assays is missing (Freedman et al., 2015; Pamies et al., 2017).”
BackgroundMethodPamies, D. (2018) · ALTEX · doi:10.14573/altex.1710081 · Cited by 127 · cited 1×
“…there is guidance available for Good In Vitro Methods Practices in general (OECD, 2018) or stem cell-based Good Cell Culture Practice specifically (Pamies et al., 2017, 2018, 2020), giving detailed insights into the broad subject of quality assurance (QA) and quality control (QC) of in vitro…”
BackgroundCell contamination leads to inaccurate data: we must take action now
Stacey, G. N. (2000) · Nature · doi:10.1038/35000394 · Cited by 125 · cited 1×
“Up to 40% of all analyzed cell lines have been falsely identified (Nelson-Rees et al., 1981; MacLeod et al., 1999; Stacey et al., 2000; Buehring et al., 2004; Hughes et al., 2007; Rojas et al., 2008; Dirks et al., 2010; Yu et al., 2015).”
BackgroundKleensang, A., Vantangoli, M. M., Odwin-DaCosta, S., Andersen, M. E., Boekelheide, K., Bouhifd, M., Fornace, A. J., Li, H.-H., Livi, C. B., Madnick, S., et al. (2016) · Scientific Reports · doi:10.1038/srep28994 · Cited by 114 · cited 1×
“Nevertheless, another drawback of these high-resolution methods is that while they provide a lot of data, they lack a definition of what differences may impact the reproducibility of research (Kleensang et al., 2016).”
BackgroundDirks, W. G., MacLeod, R. A. F., Nakamura, Y., Kohara, A., Reid, Y., Milch, H., Drexler, H. G., & Mizusawa, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.24999 · Cited by 104 · cited 1×
“Up to 40% of all analyzed cell lines have been falsely identified (Nelson-Rees et al., 1981; MacLeod et al., 1999; Stacey et al., 2000; Buehring et al., 2004; Hughes et al., 2007; Rojas et al., 2008; Dirks et al., 2010; Yu et al., 2015).”
BackgroundAssou, S., Bouckenheimer, J., & De Vos, J. (2018) · Stem Cells · doi:10.1002/stem.2797 · Cited by 81 · cited 4×
“…methods to assess the self-renewal capacity of hiPSCs include immunocytochemical staining for alkaline phosphatase and intracellular markers (Nanog, POUF1, GDF3, DNMT3B), identification of cell surface stem cell markers (SSEA3, SSEA4, TRA-1-60, TRA-1-81) via flow (Assou et al., 2018).”
BackgroundMethodInfluentialO'Shea, O., Steeg, R., Chapman, C., Mackintosh, P., & Stacey, G. N. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.101773 · Cited by 59 · cited 2×
“, 2016), but until recently were not able to detect inversions or balanced rearrangements (O’Shea et al., 2020).”
BackgroundThe scope of mycoplasma contamination within the biopharmaceutical industry
Armstrong, S. E., Mariano, J. A., & Lundin, D. J. (2010) · Biologicals · doi:10.1016/j.biologicals.2010.03.002 · Cited by 56 · cited 2×
“occurrence of chromosomal aberrations (Drexler and Uphoff, 2002), altered cellular metabolism (Armstrong et al., 2010), changes in cell membrane antigenicity (Timenetsky et al.”
Background
Cited by
Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0)
Pamies, D. (2021) · ALTEX · doi:10.14573/altex.2111011 · Cited by 100
Pamies, D., Ekert, J., Zurich, M.-G., Frey, O., Werner, S., Piergiovanni, M., Freedman, B. S., Keong Teo, A. K., Erfurth, H., Reyes, D. R., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.03.009 · Cited by 88
Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation
Koch, K., Bartmann, K., Hartmann, J., Kapr, J., Klose, J., Kuchovská, E., Pahl, M., Schlüppmann, K., Zühr, E., & Fritsche, E. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.816370 · Cited by 48
Self-citationHartmann, J., Henschel, N., Bartmann, K., Dönmez, A., Brockerhoff, G., Koch, K., & Fritsche, E. (2023) · Cells · doi:10.3390/cells12091270 · Cited by 31
Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells
Pistollato, F., Bal-Price, A., Coecke, S., Parvatam, S., Pamies, D., Czysz, K., Hao, J., Kee, K., Teo, A. K. K., Niu, S., et al. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.06.003 · Cited by 10
Metadata
- Authors
- Tigges, J.
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2021
- Volume
- 38
- Issue
- 4
- Pages
- 595-614
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W3158741845
- Cited by
- 19
- References
- 25
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.